SPINK1 overexpression was also positively correlated with prostate cancer-specific mortality in patients with biochemical and clinical recurrence after prostatectomy [50], and the relationship between SPINK1 and biochemical recurrence after surgical resection was exclusively shown in patients with aggressive subtypes of ETS-negative prostate cancers [45]. This evidence concerns the gene SPINK1 and prostate carcinoma.